Korean Government Accelerates Support For Homegrown Biosimilars

SEOUL - While South Korea's FDA is getting ready to release its initial version of registration guidelines for biosimilars, the Ministry for Knowledge Economy said it would use public funds to help local pharma and biotech companies to compete in the biosimilar arena